Navigation Links
Cephalon Exceeds Both Sales and Earnings Guidance for Second Quarter of 2008
Date:7/29/2008

10%

GABITRIL 10% (33%) 2%

CNS 8% 21% 9%

ACTIQ (30%) 40% (19%)

Generic OTFC (6%) - (6%)

FENTORA 0% - 0%

AMRIX 100% - 100%

Pain (1%) 40% 3%

TREANDA 100% - 100%

Other (8%) 34% 26%

Oncology 295% 34% 86%

Other 4% 12% 10%

9% 22% 11%

Six Months Ended

June 30,

2008 2007

United United

States Europe Total States Europe Total

Sales:

PROVIGIL $417,411 $30,635 $448,046 $391,192 $24,267 $415,459

GABITRIL 25,438 4,332 29,770 26,862 5,387 32,249

CNS 442,849 34,967 477,816 418,054 29,654 447,708

ACTIQ 75,568 26,333 101,901 111,151 18,631 129,782

Generic OTFC 56,276 - 56,276 64,873 - 64,873

FENTORA 75,307 - 75,307 68,031 - 68,031

AMRIX 26,887 - 26,887 - - -

Pain 234,038 26,333 260,371 244,055 18,631 262,686

TREANDA 14,381 - 14,381 - - -

Other 9,568 47,642 57,210
'/>"/>

SOURCE Cephalon, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
2. Cephalon, Inc. Announces Agreement to Acquire AMRIX, A Once-Daily Extended-Release Muscle Relaxant
3. Cephalon Reinforces Important Prescribing and Dosing Information for FENTORA
4. Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia
5. Cephalon Quarterly Conference Call Invitation
6. Cephalon Announces Strong Third Quarter Financial Results
7. Cephalon Submits Supplemental New Drug Application for FENTORA
8. Cephalon Submits New Drug Application for TREANDA for the Treatment of Patients with Relapsed Indolent Non-Hodgkins Lymphoma
9. Cephalon Presentation Slides for the 26th Annual JPMorgan Healthcare Conference Now Available
10. Cephalons EFFENTORA Receives Positive Opinion from European Regulatory Authorities for the Management of Breakthrough Cancer Pain
11. Cephalon Provides Update on Regulatory Status of the FENTORA Supplemental New Drug Application
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... 10, 2014 Terascala, the industry leader ... Alan Swahn, a former vice president of product management ... vice president of marketing. Terascala’s software when combined with ... create the highest performance and most reliable solutions for ... guide Terascala’s channel expansion and broaden its product portfolio. ...
(Date:7/10/2014)... 2014 Robert Harman, DVM, Founder and CEO ... proud to announce the relaunch of his highly informative blog, ... series called “ What are Stem Cells ?” Dr. ... straightforward foundation in the basics of stem cell therapy so ... right type of treatment when considering regenerative medicine. , A ...
(Date:7/10/2014)... 10, 2014 EvoDerma ’s NOOME Anti-Aging ... rejuvenating device now comes with a second treatment cup to ... , The new cup is thinner on the edges for ... target rough, thin and uneven surfaces on the face, neck ... a stimulating treatment on areas such as the cheeks and ...
(Date:7/10/2014)... 10, 2014  Franciscan St. Anthony Health-Crown ... for respiratory monitoring outside the operating room, ... in embracing state-of-the-art patient safety technology. ... breathing and can alert medical caregivers when ... amount of carbon dioxide the patient is ...
Breaking Biology Technology:Terascala Expands Executive Team 2Terascala Expands Executive Team 3Robert Harman, DVM Talks About What Stem Cells are in His Latest Blog Series for Vet-Stem, Inc. 2Robert Harman, DVM Talks About What Stem Cells are in His Latest Blog Series for Vet-Stem, Inc. 3Introducing a New Bonus Treatment Cup for EvoDerma’s NOOME Anti-Aging Motion 2Franciscan St. Anthony Health-Crown Point Underscores Patient Safety Commitment Through Expanded Use of Capnography 2
... To thrive in today,s,competitive and changing marketplace, sales ... performance doesn,t just happen. Productive,companies train, structure, deploy, ... field-performance to ensure high success rates., Best ... their sales forces to evolve and mature to ...
... Part Of Georgetown University Hospital Arsenal Against ... ... Sciences (OTC,Bulletin Board: DSCI), a provider of advanced wound care products,announced ... Leptospermum Honey, has been used by clinicians at Georgetown,University Hospital,s Wound ...
... Danube Pharmaceuticals, Inc., a,privately held biopharmaceutical company ... drugs for ophthalmology, is pleased,to announce the appointment ... Chief,Executive Officer., "I am honored and delighted ... its history as it advances its lead programs ...
Cached Biology Technology:Increasing Sales Productivity Through Superior Sales Force Performance Management 2Derma Sciences MEDIHONEY(TM) Helps to Save Patient's Limb 2Derma Sciences MEDIHONEY(TM) Helps to Save Patient's Limb 3Derma Sciences MEDIHONEY(TM) Helps to Save Patient's Limb 4Barrett Katz, MD, MBA, Named CEO of Danube Pharmaceuticals 2Barrett Katz, MD, MBA, Named CEO of Danube Pharmaceuticals 3
(Date:7/11/2014)... division of the striatum is also involved in ... of substance P in the striatal marginal division ... his team, College of Biophotonics, South China Normal ... P receptor, neurokinin 1 was highly expressed in ... rats. Unilateral or bilateral injection of an antisense ...
(Date:7/11/2014)... -- Research and Markets has announced the ... Industry Analysis Size Share Growth Trends and Forecast to ... http://photos.prnewswire.com/prnh/20130307/600769 The rising number ... for high level security in both private and public ... username and passwords, tokens etc. are vulnerable to attacks. ...
(Date:7/10/2014)... in New Mexico, nearly every public golf course is ... potable water supplies. Across the U.S. Southwest as a ... treated effluent. Reusing the effluent increases the sustainability of ... alike fertilize their lawns during the growing season. The ... State University turfgrass expert has a new vision for ...
Breaking Biology News(10 mins):International Biometrics Technology Market - Industry Analysis Size Share Growth Trends and Forecast to 2019 2'Tailored' water -- the latest in lawn care 2
... biologist at Fred Hutchinson Cancer Research Center, has received the ... Pfizer Inc., the award consists of a $25,000 prize in ... , She was among 18 honored by NAS this year ... the physical, biological and social sciences. , Biggins, a ...
... LA JOLLA, CA January 8, 2013 - Chemists at The ... one of the most fundamental tasks in molecular biology. Their new ... that these cells may be easily located and/or selected out from ... in a recent issue of the chemistry journal Angewandte Chemie ...
... Qubcois en Reproduction (RQR), Palais des congrs de Montral, Montral, ... Submissions: 15 February 2013 -- The Society for the ... for presentation at the 46th SSR Annual Meeting to be ... visit the SSR Meetings page ( http://www.ssr.org/Meetings.shtml ) for details; ...
Cached Biology News:National Academy of Sciences honors geneticist and biologist Sue Biggins 2Chemists devise inexpensive, benchtop method for marking and selecting cells 2Chemists devise inexpensive, benchtop method for marking and selecting cells 3
Donor feline serum and plasma...
8 different frozen tissues are mounted on positively charged glass slides...
... cups provide flexible sealing lips for ... surfaces. ,PFG: Flat cup ,PBG: Bellows ... Multiple Bellows cup , Range ... 200 mm , Multiple suction cup ...
XA7 B6...
Biology Products: